Evaluation of the Antioxidant Effectiveness in Reduction of the Dry Eye Syndrome among Patients with Relevant Toxicoallergic Component and a Severe Case of Corneal-Conjunctival Xerosis

Currently the ophthalmologists meet with corneal-conjunctival xerosis more often in their daily practice. The objective of this research is identifying a new alternative method of treatment of the dry eye syndrome of different severity. In this work there will be a demonstration and the results of usage of BAA Delphanto® in treatment of different cases of the dry eye syndrome. The data collected from a dynamic research of groups of patients reveals the effectiveness of the comprehensive therapy with the use of BAA Delphanto®. Consequently, the research results demonstrate an improvement of the initial data from the biomicroscopy, OSDI index, Schirmer-1 test and the tear break up time. The statistically significant results were received reveal the effectiveness of the use of BAA Delphanto® with a significant improvement of the quality of life. It can be used widely by ophthalmologists for the treatment of corneal-conjunctival xerosis of different severity.

1. Brzheskii V.V. Dry eye syndrome — a disease of civilization: modern diagnostic and treatment options. Medical council = Medicinskiy sovet. 2013;3:114– 116 (In Russ.).

2. Brzheskii V.V., Popov V.Yu., Kalinina N.M., Brzheskaya I.V. Prophylaxis and treatment of the degenerative changes of the eye surface epithelium in dry eye syndrome. Annals of Ophthalmology = Vestnik oftal’mologii. 2018;134(5):126–134 (In Russ.). DOI: 10.18008/1816-5095-2019-2-244-251

3. Murube J., Wilson St., Ramos-Esteban J. The important developments in dry eye. Highlights of Ophthalmology. 2001;29(5):54–66.

4. O’Neil E.C., Henderson M., Massaro-Giordano M., Bunya V.Y. Advances in dry eye disease treatment. Curr Opin Ophthalmol. 2019;30(3):166–178. DOI: 10.1097/ ICU.0000000000000569

5. Maуchuk D.Yu., Loshkareva A.O., Tsvetkova T.V. The Complex Treatment Algorithm for Dry Eye Syndrome with Meibomian Gland Dysfunction. Combination of Intense Pulsed Light (IPL) with Eyelid Hygiene and Artificial Tears. Ophthalmology in Russia = Oftal’mologiya. 2020;17(3s):640–647 (In Russ.). DOI: 10.18008/1816-50952020-3S-640-647

6. Brzheskii V.V., Popov V.Yu., Kalinina N.M., Brzheskaya I.V. Prophylaxis and treatment of the degenerative changes of the eye surface epithelium in dry eye syndrome. Annals of Ophthalmology = Vestnik oftal’mologii 2018;134(5):126–134 (In Russ.). DOI: 10.18008/1816-5095-2019-2-244-251

7. Nakamura S., Shibuya M., Nakashima H., Imagawa T., Uehara M., Tsubota K. D-βhydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board. Investigative Ophthalmology & Visual Science. 2005;46(7):2379– 2387. DOI: 10.1167/iovs.04-1344

8. Foulks G.N. The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol. 2007;52(4):369–374. DOI: 10.1016/j.survophthal.2007.04.009

9. Brzheskii V.V., Popov V.Yu., Kalinina N.M., Brzheskaya I.V. Prophylaxis and treatment of the degenerative changes of the eye surface epithelium in dry eye syndrome. Annals of Ophthalmology = Vestnik oftal’mologii. 2018;134(5):126–134 (In Russ.). DOI: 10.18008/1816-5095-2019-2-244-251

10. Maуchuk D.Yu., Loshkareva A.O. Peculiarities of Treatment for Patients with Dry Eye Syndrome, Including Those with Epitheliopathy. Ophthalmology in Russia = Oftal’mologiya. 2019;16(4):529–536 (In Russ.). DOI: 10.18008/1816-5095-2019-4-529-536

11. Maychuk D.Yu., Pronkin I.A., Kolubelova Yu.V. Filamentary keratitis etiology analysis, its combination with systemic diseases and etiopathogenic treatment regimens. Fyodorov Journal of Ophthalmic Surgery = Oftal’mohirurgiya. 2014;4:35–40 (In Russ.).

12. Pronkin I.A., Maychuk D.Yu. Modern technologies in ophthalmology = Sovremennye tekhnologii v oftal’mologii. 2016;3(11):25–29 (In Russ.).

13. Pronkin I.A., Maychuk D.Yu. Corneal erosions: etiology, pathogenesis, methods of diagnostics and treatment. Ophthalmosurgery = Oftal’mokhirurgiya. 2015;1:62–67 (In Russ.).

14. Brzeski V.V., Egorova G.B., Egorov E.A. “Dry eye” syndrome and ocular surface disease: clinic, diagnostics, treatment. Moscow: GEOTAR-Media, 2016. 464 p. (In Russ.).

15. Polunin G.S., Zabegaylo A.O., Makarov I.A., Safonova T.N., Polunina E.G., Zhemchugova A.V., Alieva A. The efficiency of tear substitute therapy at dysfunction tear basic secretion. Ophthalmology in Russia = Oftal’mologiya. 2012;9(3):93–97 (In Russ.). DOI: 10.18008/1816-5095-2012-3-93-97

16. Barabino S., Rolando M., Camicione P. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea. 2003;22(2):97–101. DOI: 10.1097/00003226-200303000-00002

17. Rashid S., Jin Y., Ecoiffier T., Barabino S., Schaumberg D.A., Dana M.R. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol. 2008;126(2):219–225. DOI: 10.1001/archophthalmol.2007.61

18. Prozornaya L.P., Brzheskiy V.V. Efficacy of physiotherapy and hygienic procedures in treatment of adults and children with chronic blepharitis and dry eye syndrome. Annals of Ophthalmology = Vestnik oftal’mologii. 2013;129(3):68–73 (In Russ.).

19. Safonova T.N., Zabegaylo A.O., Fedorov A.A., Lukicheva O.V. New method of treatment for chronic blepharitis associated with dry eye syndrome. Annals of Ophthalmology = Vestnik oftal’mologii. 2014;130(1):73–78 (In Russ.).

20. Polunin G.S., Zabegaylo A.O., Makarov I.A., Safonova T.N., Polunina E.G. Efffectiveness of therapeutic eyelid hygiene in the treatment of patients with blepharococojunctival dry eye syndrome. Annals of Ophthalmology = Vestnik oftal’mologii. 2012;1:37–40 (In Russ.).

21. Wakamatsu T.H., Dogru M., Tsubota K. Tearful relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol. 2008;71(6):72–79. DOI: 10.1590/ s0004-27492008000700015

22. Tanaka J, Kadekaru T, Ogawa K, Hitoe S, Shimoda H, Hara H. Maqui berry (Aristotelia chilensis) and the constituent delphinidin glycoside inhibit photoreceptor cell death induced by visible light. Food Chem. 2013 Aug 15;139(1-4):129-37. doi: 10.1016/j.foodchem.2013.01.036.23.

23. Yamashita S.I., Suzuki N., Yamamoto K., Iio S.I., Yamada T. Effects of MaquiBright® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial. Journal of Traditional and Complementary Medicine. 2018;22;9(3):172–178. DOI: 10.1016/j.jtcme.2018.11.001

24. Misle E., Garrido E., Contardo H., González W. Maqui [Aristotelia chilensis (Mol.) Stuntz]-the amazing chilean tree: a review. Journal of Agricultural Science and Technology. 2011:(B1):473–482.

25. Muñoz O., Christen P., Cretton S. Chemical study and anti-inflammatory, analgesic and antioxidant activities of the leaves of Aristotelia chilensis (Mol.) Stuntz, Elaeocarpaceae. J Pharm Pharmacol. 2011;63(6):849–859.

26. Nakamura S., Tanaka J., Imada T., Shimoda H., Tsubota K. Delphinidin 3,5-Odiglucoside, a constituent of the maqui berry (Aristotelia chilensis) anthocyanin, restores tear secretion in a rat dry eye model. J Funct Foods. 2014;10:346–354.

27. Huang JY, Yeh PT, Hou YC. A randomized, double-blind, placebo-controlled study of oral antioxidant supplement therapy in patients with dry eye syndrome. Clin Ophthalmol. 2016 May 9;10:813-20. doi: 10.2147/OPTH.S106455.1

28. Davinelli S., Bertoglio J.C., Zarrelli A., Pina R., Scapagnini G. A Randomized Clinical Trial Evaluating the Efficacy of an Anthocyanin-Maqui Berry Extract (Delphinol®) on Oxidative Stress Biomarkers. J Am Coll Nutr. 2015;34(1):28–33. DOI: 10.1080/07315724.2015.1080108

29. Hitoe S., Tanaka J., Shimoda H. MaquiBright™ standardized maqui berry extract significantly increases tear fluid production and ameliorates dry eye-related symptoms in a clinical pilot trial. Panminerva Med. 2014;56(3 Suppl 1):1–6.